Seizures
- Seizures in Children. Pediatr Rev. 2020;41(7):321-347
- Update on Antiseizure Medications 2022. Epilepsy. 2022;28(2):500-535
- Seizures and Epilepsy in Childhood. Epilepsy. 2022;28(2):428-456
- Approach to the Medical Treatment of Epilepsy. Epilepsy. 2022;28(2):483-499
- Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy. Neurology. 2018;91:74-81
- Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy. Neurology. 2019;91:82-90
- Antiseizure Medication Withdrawal in Seizure-Free Patients. Neurology. 2021;97(23):1072-1081
- Medical treatment of infantile spasms. Neurology. 2012;78:1974-1980
- The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. The Lancet. 2005;4(11):712-717
Status Epilepticus
- Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb;16(1):48-61
- Guidelines for the Evaluation and Management of Status Epilepticus. Neurocrit Care. 2012;17:3-23
- Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus. Epilepsy. 2022;28(2): 559-602
Ketogenic Diet
- Carbohydrate Content of Medication Reference
- Lexicomp Carbohydrate Content of Medication Reference (search ‘carbohydrate content’ in Lexi)
- Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018; 3(2):175-192
- International Recommendations for the Management of Adults Treated With Ketogenic Diet Therapies. Neurol Clin Pract. 2021 Oct; 11(5):385-397
- Charlie Foundation for Ketogenic Therapies (patient resource site)
- Medication Management on the Ketogenic Diet
- Carbohydrate Content of Medications Reference
Cerebral Palsy
- Quality Standards Subcommittee of the American Academy of Neurology, Practice Committee of the Child Neurology Society. Practice parameter: pharmacologic treatment of spasticity in children with cerebral palsy (an evidence-based review).Neurology. 2010 Jan 26;74(4):336-43
- Cerebral palsy in children: a clinical overview. Transl Pediatr. 2020 Feb; 9(Suppl 1): S125-S135
Migraine/Headache
- Headache in Children. Pediatr Rev (2020) 41 (4): 159–171
- Pharmacologic treatment for pediatric migraine prevention. Neurology. 2019;93:500-509
- Acute treatment of migraine in children and adolescents. Neurology. 2019;93:487-499
- Pediatric Migraine Variants: a Review of Epidemiology, Diagnosis, Treatment, and Outcome. Curr Neurol Neurosci Rep (2015) 15: 34
